TNGX TANGO THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, TANGO THERAPEUTICS INC reported revenue of $0 (down 100.0% from a year earlier), net income of −$55.3M and diluted EPS of −$0.37; over the last four quarters revenue was $53.8M and net income −$124M; for the fiscal year ended December 2025 revenue was $62.4M, up 48.3% on the year before.
TNGX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $62.4M, gross profit n/a, operating income −$111M, net income −$102M (margin -162.9%), EPS −$0.87
- Fiscal year ended Dec 2024: revenue $42.1M, gross profit n/a, operating income −$146M, net income −$130M (margin -309.7%), EPS −$1.19
- Fiscal year ended Dec 2023: revenue $36.5M, gross profit n/a, operating income −$114M, net income −$102M (margin -278.4%), EPS −$1.08
- Fiscal year ended Dec 2022: revenue $24.9M, gross profit n/a, operating income −$111M, net income −$108M (margin -435.1%), EPS −$1.23
- Fiscal year ended Dec 2021: revenue $37.0M, gross profit n/a, operating income −$58.2M, net income −$58.2M (margin -157.2%), EPS −$0.94
TNGX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0 (down 100.0% year over year), net income −$55.3M, EPS −$0.37
- Quarter ended Mar 31, 2026: revenue $0 (down 100.0% year over year), net income −$45.5M, EPS −$0.32
- Quarter ended Dec 31, 2025 (from the annual report): revenue $0 (down 100.0% year over year), net income −$38.8M, EPS −$0.29
- Quarter ended Sep 30, 2025: revenue $53.8M (up 363.6% year over year), net income $15.9M, EPS $0.13
- Quarter ended Jun 30, 2025: revenue $3.18M (down 84.0% year over year), net income −$38.9M, EPS −$0.35
- Quarter ended Mar 31, 2025: revenue $5.39M (down 16.7% year over year), net income −$39.9M, EPS −$0.36
- Quarter ended Dec 31, 2024 (from the annual report): revenue $4.12M (down 24.2% year over year), net income −$37.7M, EPS −$0.33
- Quarter ended Sep 30, 2024: revenue $11.6M (up 8.2% year over year), net income −$29.2M, EPS −$0.27
- Quarter ended Jun 30, 2024: revenue $19.9M (up 36.1% year over year), net income −$25.6M, EPS −$0.24
- Quarter ended Mar 31, 2024: revenue $6.47M (up 12.2% year over year), net income −$37.9M, EPS −$0.35
- Quarter ended Dec 31, 2023 (from the annual report): revenue $5.43M (down 15.3% year over year), net income −$30.7M, EPS −$0.30
- Quarter ended Sep 30, 2023: revenue $10.7M (up 55.1% year over year), net income −$22.3M, EPS −$0.23
- Quarter ended Jun 30, 2023: revenue $14.6M (up 153.0% year over year), net income −$20.7M, EPS −$0.23
- Quarter ended Mar 31, 2023: revenue $5.77M (up 0.1% year over year), net income −$28.0M, EPS −$0.32
- Quarter ended Dec 31, 2022 (from the annual report): revenue $6.41M (up 12.2% year over year), net income −$29.1M, EPS −$0.33
- Quarter ended Sep 30, 2022: revenue $6.92M (up 2.0% year over year), net income −$29.1M, EPS −$0.33
- Quarter ended Jun 30, 2022: revenue $5.77M (down 68.2% year over year), net income −$24.9M, EPS −$0.28
- Quarter ended Mar 31, 2022: revenue $5.76M (down 9.8% year over year), net income −$25.2M, EPS −$0.29
- Quarter ended Dec 31, 2021 (from the annual report): revenue $5.72M, net income −$22.0M, EPS −$0.28
- Quarter ended Sep 30, 2021: revenue $6.79M, net income −$19.6M, EPS −$0.28
TNGX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$139M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$132M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$118M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$109M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$59.5M, share buybacks n/a
TNGX balance sheet
- Jun 30, 2026: cash $346M, total assets $1.07B, total liabilities $49.3M, shareholders' equity $1.02B
- Mar 31, 2026: cash $158M, total assets $436M, total liabilities $44.3M, shareholders' equity $392M
- Dec 31, 2025: cash $112M, total assets $399M, total liabilities $52.5M, shareholders' equity $346M
- Sep 30, 2025: cash $58.3M, total assets $210M, total liabilities $50.1M, shareholders' equity $160M
- Jun 30, 2025: cash $39.3M, total assets $238M, total liabilities $103M, shareholders' equity $135M
- Mar 31, 2025: cash $58.4M, total assets $274M, total liabilities $108M, shareholders' equity $167M
- Dec 31, 2024: cash $69.5M, total assets $316M, total liabilities $117M, shareholders' equity $200M
- Sep 30, 2024: cash $53.1M, total assets $352M, total liabilities $123M, shareholders' equity $229M
What is TNGX's revenue?
TANGO THERAPEUTICS INC reported $53.8M of revenue over its last four quarters, through June 30, 2026.
Is TNGX profitable?
No. TANGO THERAPEUTICS INC lost $124M over the last four quarters.
What is TNGX's EPS?
Diluted earnings per share over the last four quarters were −$0.85; −$0.37 in the latest quarter.